Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.6817
Abstract: Importance To our knowledge, there has been no update on the prevalence of chronic kidney disease (CKD) in China since 2012. Objective To provide periodic nationwide data on the prevalence of CKD and the associated… read more here.
Keywords: disease; prevalence; kidney; ckd ... See more keywords
Progression and Regression of Chronic Kidney Disease by Age Among Adults in a Population-Based Cohort in Alberta, Canada
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.12828
Abstract: Key Points Question How likely is regression of mild to severe chronic kidney disease (CKD) in adults? Findings In this population-based cohort study of adults with incident CKD, the 5-year probability of regression was similar… read more here.
Keywords: regression; chronic kidney; ckd; progression ... See more keywords
Association of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2022.2299
Abstract: Importance The evidence linking chronic kidney disease (CKD) to spontaneous intracerebral hemorrhage (ICH) is inconclusive owing to possible confounding by comorbidities that frequently coexist in patients with these 2 diseases. Objective To determine whether there… read more here.
Keywords: ckd; risk; association; intracerebral hemorrhage ... See more keywords
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2025.2590
Abstract: Importance Cisplatin is a widely used treatment for cancer that can permanently damage the kidneys. Treatment modifications and other strategies may prevent chronic kidney disease (CKD) in patients at risk; however, the incidence and predictability… read more here.
Keywords: ckd; egfr; treatment; cisplatin ... See more keywords
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Pediatrics"
DOI: 10.1001/jamapediatrics.2017.2914
Abstract: Importance Conventional methods to diagnose and monitor chronic kidney disease (CKD) in children, such as creatinine level and cystatin C–derived estimated glomerular filtration rate (eGFR) and assessment of proteinuria in spot or timed urine samples,… read more here.
Keywords: supar levels; progression; ckd; kidney disease ... See more keywords
Implementing an evidence-based clinical decision support tool to improve the detection, evaluation, and referral patterns of adult chronic kidney disease patients in primary care
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Association of Nurse Practitioners"
DOI: 10.1002/2327-6924.12505
Abstract: Background and purpose Chronic kidney disease (CKD) is undertreated and under-recognized in primary care. The majority of primary care providers (PCPs) are not aware or knowledgeable of current CKD guidelines. The purpose of this project… read more here.
Keywords: primary care; tool; ckd; care ... See more keywords
Flavokawain A Attenuated Chronic Kidney Disease: Evidence From Network Pharmacology and Experimental Verification
Sign Up to like & getrecommendations! Published in 2025 at "Cell Biology International"
DOI: 10.1002/cbin.70036
Abstract: Chronic kidney disease (CKD) is a silent global epidemic affecting ~700 million people worldwide, contributing to rising mortality rates. Despite the variety of underlying causes, renal fibrosis is the key pathological feature of CKD. Flavokawain… read more here.
Keywords: ckd; network pharmacology; kidney disease; pharmacology ... See more keywords
It is all about the beans: How chronic kidney disease can affect outcomes in peripheral intervention
Sign Up to like & getrecommendations! Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29850
Abstract: While many guidelines do not specifically identify chronic kidney disease (CKD) as a risk factor for peripheral arterial disease (PAD), the incidence of PAD is higher in patients with CKD. PAD is also an independent… read more here.
Keywords: risk; patients ckd; disease; patient ckd ... See more keywords
Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically‐Based Pharmacokinetic Modeling and Dose Adjustment
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2642
Abstract: There is growing evidence that active tubular secretory clearance (CLs) may not decline proportionally with the glomerular filtration rate (GFR) in chronic kidney disease (CKD), leading to the overestimation of renal clearance (CLr) when using… read more here.
Keywords: disease; chronic kidney; ckd; oat1 ... See more keywords
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of heart failure"
DOI: 10.1002/ejhf.2857
Abstract: BACKGROUND In the EMPEROR-Preserved trial, empagliflozin improved clinical outcomes of patients with heart failure with preserved ejection fraction. In this pre-specified analysis, we aim to study the effect of empagliflozin on cardiovascular and kidney outcomes… read more here.
Keywords: emperor preserved; heart failure; without ckd; kidney ... See more keywords
Safety of Oral Bisphosphonates in Moderate‐to‐Severe Chronic Kidney Disease: A Binational Cohort Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4235
Abstract: Bisphosphonates are the first‐line treatment for preventing fractures in osteoporosis patients. However, their use is contraindicated or to be used with caution in chronic kidney disease (CKD) patients, primarily because of a lack of information… read more here.
Keywords: chronic kidney; safety; disease; ckd ... See more keywords